These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 31179880)

  • 1. Severe pulmonary infections complicating nivolumab treatment for lung cancer: a report of two cases.
    Inthasot V; Bruyneel M; Muylle I; Ninane V
    Acta Clin Belg; 2020 Aug; 75(4):308-310. PubMed ID: 31179880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive Pulmonary Aspergillosis Complicated by Carbapenem-Resistant Pseudomonas aeruginosa Infection During Pembrolizumab Immunotherapy for Metastatic Lung Adenocarcinoma: Case Report and Review of the Literature.
    Oltolini C; Ripa M; Andolina A; Brioschi E; Cilla M; Petrella G; Gregorc V; Castiglioni B; Tassan Din C; Scarpellini P
    Mycopathologia; 2019 Feb; 184(1):181-185. PubMed ID: 30101407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy-Induced Airway Disease: A New Pattern of Lung Toxicity of Immune Checkpoint Inhibitors.
    Mitropoulou G; Daccord C; Sauty A; Pasche A; Egger B; Aedo Lopez V; Letovanec I; Beigelman-Aubry C; Nicod LP; Lazor R
    Respiration; 2020; 99(2):181-186. PubMed ID: 31914436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching administration of anti-PD-1 and anti-PD-L1 antibodies as immune checkpoint inhibitor rechallenge in individuals with advanced non-small cell lung cancer: Case series and literature review.
    Kitagawa S; Hakozaki T; Kitadai R; Hosomi Y
    Thorac Cancer; 2020 Jul; 11(7):1927-1933. PubMed ID: 32421224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nivolumab-related severe thrombocytopenia in a patient with relapsed lung adenocarcinoma: a case report and review of the literature.
    Hasegawa T; Ozaki Y; Inoue T; Watanabe Y; Fukuhara M; Yamaura T; Muto S; Okabe N; Higuchi M; Shio Y; Suzuki H
    J Med Case Rep; 2019 Oct; 13(1):316. PubMed ID: 31647029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Checkpoint Inhibitor-Related Pulmonary Toxicity: Focus on Nivolumab.
    Bukamur H; Katz H; Alsharedi M; Alkrekshi A; Shweihat YR; Munn NJ
    South Med J; 2020 Nov; 113(11):600-605. PubMed ID: 33140115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune checkpoint inhibitor-associated interstitial lung diseases correlate with better prognosis in patients with advanced non-small-cell lung cancer.
    Sugano T; Seike M; Saito Y; Kashiwada T; Terasaki Y; Takano N; Hisakane K; Takahashi S; Tanaka T; Takeuchi S; Miyanaga A; Minegishi Y; Noro R; Kubota K; Gemma A
    Thorac Cancer; 2020 Apr; 11(4):1052-1060. PubMed ID: 32096610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of pulmonary tuberculosis that developed during nivolumab and ipilimumab treatment for pulmonary adenocarcinoma that recurred two months after completion of anti-tuberculous treatment.
    Hirano S; Takahashi H; Nakamura S; Matsuda K; Ishikawa R; Tamura K; Shikano K; Fujita T; Amano H; Nakamura M
    Chin Clin Oncol; 2024 Jun; 13(3):43. PubMed ID: 38859608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nivolumab-induced adrenalitis.
    Iqbal I; Khan MAA; Ullah W; Nabwani D
    BMJ Case Rep; 2019 Dec; 12(11):. PubMed ID: 31791986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Can nivolumab be used safely in idiopathic pulmonary fibrosis?].
    Duchemann B; Didier M; Pailler MC; Brillet PY; Kambouchner M; Uzunhan Y; Freynet O; Chouahnia K; Zelek L; Nunes H
    Rev Mal Respir; 2019 Feb; 36(2):209-213. PubMed ID: 30686563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe nivolumab-induced pneumonitis preceding durable clinical remission in a patient with refractory, metastatic lung squamous cell cancer: a case report.
    Li H; Ma W; Yoneda KY; Moore EH; Zhang Y; Pu LL; Frampton GM; Molmen M; Stephens PJ; Li T
    J Hematol Oncol; 2017 Feb; 10(1):64. PubMed ID: 28245875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nivolumab increases pulmonary artery pressure in patients treated for non-small cell lung cancer.
    Fournel L; Boudou-Rouquette P; Prieto M; Hervochon R; Guinet C; Arrondeau J; Alexandre J; Damotte D; Wislez M; Batteux F; Icard P; Goldwasser F; Alifano M
    Cancer Chemother Pharmacol; 2020 Oct; 86(4):497-505. PubMed ID: 32936316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature.
    Ohara N; Kobayashi M; Ohashi K; Ito R; Ikeda Y; Kawaguchi G; Yoneoka Y; Hasegawa G; Takada T
    J Med Case Rep; 2019 Mar; 13(1):88. PubMed ID: 30909965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-transcriptional intermediary factor 1-γ antibody-positive dermatomyositis induced by nivolumab for lung adenocarcinoma: A case report.
    Osaki M; Tachikawa R; Ohira J; Hara S; Tomii K
    Invest New Drugs; 2021 Feb; 39(1):251-255. PubMed ID: 32651759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of pulmonary tuberculosis following treatment with anti-PD-1 for non-small cell lung cancer.
    Jensen KH; Persson G; Bondgaard AL; Pøhl M
    Acta Oncol; 2018 Aug; 57(8):1127-1128. PubMed ID: 29384034
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of immune checkpoint inhibitors according to PD-L1 tumor proportion scores in non-small cell lung cancer.
    Park S; Choi YD; Kim J; Kho BG; Park CK; Oh IJ; Kim YC
    Thorac Cancer; 2020 Feb; 11(2):408-414. PubMed ID: 31841269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nivolumab-associated Stevens-Johnson syndrome in a patient with lung cancer.
    Gracia-Cazaña T; Padgett E; Calderero V; Oncins R
    Dermatol Online J; 2021 Mar; 27(3):. PubMed ID: 33865285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Third degree atrio-ventricular blockade during a myocarditis occurring under anti-PD1 : Case report and literature review].
    Prevel R; Colin G; Calès V; Renault PA; Mazieres J
    Rev Med Interne; 2020 Apr; 41(4):284-288. PubMed ID: 31983550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bullous Lupus Under Nivolumab Treatment for Lung Cancer: A Case Report With Systematic Literature Review.
    Wouters A; Durieux V; Kolivras A; Meert AP; Sculier JP
    Anticancer Res; 2019 Jun; 39(6):3003-3008. PubMed ID: 31177141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy.
    Canale ML; Camerini A; Casolo G; Lilli A; Bisceglia I; Parrini I; Lestuzzi C; Del Meglio J; Puccetti C; Camerini L; Amoroso D; Maurea N
    Adv Ther; 2020 Jul; 37(7):3178-3184. PubMed ID: 32436027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.